+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Connected Drug Delivery Devices Market - Global Forecast 2026-2032- Product Image
Connected Drug Delivery Devices Market - Global Forecast 2026-2032- Product Image
New

Connected Drug Delivery Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6014742
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The connected drug delivery devices market is transforming pharmaceutical and healthcare delivery, blending smart technologies with robust supply chains to optimize patient outcomes, operational efficiency, and commercial performance.

Market Snapshot: Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market grew from USD 4.98 billion in 2025 to USD 5.81 billion in 2026. It is expected to continue growing at a CAGR of 18.90%, reaching USD 16.75 billion by 2032. Digital integration, analytics, and new service models are redefining competitive dynamics as organizations prioritize innovation and patient-centric care.

Scope & Segmentation

  • Device Types: Connected infusion pumps (enteral, insulin, PCA); inhalers (dry powder, metered dose, nebulizers); injection devices (autoinjectors, pen injectors, safety syringes); nasal sprays (manual and nebulized); transdermal patches (matrix and reservoir).
  • Drug Modalities: Biologics, biosimilars, small molecule drugs, and vaccines.
  • Care Settings: Hospitals, ambulatory care centers, home care, and clinics.
  • Distribution Pathways: Direct sales, hospital pharmacy, online pharmacy, retail pharmacy.
  • Technological Advances: Miniaturized sensors, low-power wireless communications, integrated analytics, algorithmic safety systems, and human-centered device design.
  • Regional Coverage: Americas, Europe Middle East & Africa, Asia-Pacific.

Key Takeaways

  • Convergence of sensors, software platforms, and healthcare services is elevating device functionality, allowing for remote titration, adherence tracking, and personalized therapy management.
  • Changing payer and regulatory priorities require integrated product development that aligns engineering, clinical validation, and reimbursement strategies for optimal adoption and lifecycle management.
  • Commercial models now mix traditional sales with recurring, data-driven service revenues, reflecting a shift toward value-added propositions and extended customer relationships.
  • Human factors and usability, including patient interface and workflow integration, increasingly impact readiness for clinical use and buyer preferences.
  • Regional adoption patterns, from home-based models in the Americas to rapid Asia-Pacific uptake and Europe’s centrally managed health systems, require locally tailored product design and go-to-market strategies.
  • Supply chain resilience, cybersecurity, and component standardization are fundamental to both regulatory compliance and business continuity.

Tariff Impact: Strategic Adjustments and Operational Implications

U.S. tariffs introduced in 2025 have driven cost pressure for manufacturers reliant on imported electronics, batteries, and polymers. This has triggered strategic sourcing shifts, including supplier diversification, nearshoring, and localized assembly. Organizations are also adopting more transparent cost analyses and lifecycle support models for procurement teams. Enhanced collaboration between manufacturers and suppliers is necessary at early stages to ensure regulatory and quality compliance amid shifting global trade dynamics.

Methodology & Data Sources

This analysis combines structured interviews with clinicians, procurement and regulatory specialists, engineers, and care coordinators. It incorporates detailed technical reviews of device specifications, protocols, and digital integration complexity. Secondary sources include regulatory guidance, technology standards, and patent filings. All input is triangulated with supply chain mapping and market evidence to provide objective, balanced insights.

Why This Report Matters

  • Enables decision-makers to understand evolving regulatory, commercial, and technical drivers shaping connected drug delivery strategies.
  • Identifies actionable regional and segmentation opportunities to optimize design, evidence generation, sourcing, and market-entry approaches.
  • Provides a roadmap for navigating challenges such as tariff impacts, supply chain disruptions, and cybersecurity threats while focusing on clinical adoption and operational value.

Conclusion

Connected drug delivery devices now bridge product engineering, clinical impact, and commercial strategy. By aligning innovation across design, compliance, and value creation, companies can capitalize on global opportunities and strengthen resilience in an evolving healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Connected Drug Delivery Devices Market, by Device Type
8.1. Infusion Pumps
8.1.1. Enteral Pumps
8.1.2. Insulin Pumps
8.1.3. PCA Pumps
8.2. Inhalers
8.2.1. Dry Powder Inhalers
8.2.2. Metered Dose Inhalers
8.2.3. Nebulizers
8.3. Injection Devices
8.3.1. Autoinjectors
8.3.2. Pen Injectors
8.3.3. Safety Syringes
8.3.4. Standard Syringes
8.4. Nasal Spray
8.4.1. Manual Spray
8.4.2. Nebulized Spray
8.5. Transdermal Patch
8.5.1. Matrix Patch
8.5.2. Reservoir Patch
9. Connected Drug Delivery Devices Market, by Drug Type
9.1. Biologics
9.2. Biosimilars
9.3. Small Molecule
9.4. Vaccines
10. Connected Drug Delivery Devices Market, by End User
10.1. Ambulatory Care Centers
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Connected Drug Delivery Devices Market, by Distribution Channel
11.1. Online
11.2. Offline
12. Connected Drug Delivery Devices Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Connected Drug Delivery Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Connected Drug Delivery Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Connected Drug Delivery Devices Market
16. China Connected Drug Delivery Devices Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Adherium Limited
17.7. AptarGroup, Inc.
17.8. Becton, Dickinson, and Company
17.9. Cognita Labs LLC
17.10. Eli Lilly and Company
17.11. F. Hoffmann-La Roche AG
17.12. Findair Sp. z o. o.
17.13. Gerresheimer AG
17.14. Medtronic PLC
17.15. Merck KGaA
17.16. Molex LLC
17.17. Novartis AG
17.18. Novo Nordisk A/S
17.19. OPKO Health, Inc.
17.20. Otsuka America, Inc.
17.21. Presspart Verwaltungs-GmbH
17.22. ResMed Inc.
17.23. SHL Medical AG
17.24. Sulzer Ltd.
17.25. Teva Pharmaceutical Industries Ltd.
17.26. Viatris Inc.
17.27. West Pharmaceutical Services, Inc.
17.28. Ypsomed Holding
17.29. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ENTERAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ENTERAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ENTERAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PCA PUMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PCA PUMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PCA PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STANDARD SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STANDARD SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MANUAL SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MANUAL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MANUAL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZED SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZED SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZED SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MATRIX PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MATRIX PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOSIMILARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 144. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 146. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 161. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 162. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 163. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 164. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 165. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 166. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 167. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 183. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 184. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 185. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 186. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 187. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. ASEAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 192. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 193. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 194. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 195. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 196. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 197. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 198. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. GCC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 212. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 213. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 214. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 215. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 216. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 217. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. BRICS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 222. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 223. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 224. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 225. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 226. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 227. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 228. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. G7 CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 232. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 233. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 234. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 235. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 236. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 237. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 238. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. NATO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 253. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
TABLE 254. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2032 (USD MILLION)
TABLE 255. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2032 (USD MILLION)
TABLE 256. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2032 (USD MILLION)
TABLE 257. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2032 (USD MILLION)
TABLE 258. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Connected Drug Delivery Devices market report include:
  • Abbott Laboratories
  • Adherium Limited
  • AptarGroup, Inc.
  • Becton, Dickinson, and Company
  • Cognita Labs LLC
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Findair Sp. z o. o.
  • Gerresheimer AG
  • Medtronic PLC
  • Merck KGaA
  • Molex LLC
  • Novartis AG
  • Novo Nordisk A/S
  • OPKO Health, Inc.
  • Otsuka America, Inc.
  • Presspart Verwaltungs-GmbH
  • ResMed Inc.
  • SHL Medical AG
  • Sulzer Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.81 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.75 Billion
Compound Annual Growth Rate18.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Smart Drug Delivery Systems Market Report 2025 - Product Image

Smart Drug Delivery Systems Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Electronic Drug Delivery Devices Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Electronic Drug Delivery Devices Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.